The clinical presentation and evolution, neuropathological findings, and genotyp-ing of three members of a Spanish family aVected with fatal familial insomnia are reported. The mother and two of her oVspring developed a rapidly evolving dis-ease with insomnia and behavioural disor-ders as the initial symptoms and died between 5 and 10 months after the onset of the illness. Frontal brain biopsy in the mother disclosed only non-significant spongiosis, and full neuropathological ex-amination of her oVspring showed tha-lamic and olivary degeneration with isolated focal cortical spongiosis. Genetic examination could only be performed in the contemporary patients and both har-boured the prion protein (PrP) 178Asn mutation and homozygous 129 Met/M...
Abstract Background Fatal familial insomnia (FFI) is a rare autosomal dominant disease caused by the...
Fatal familial insomnia (FFI) is a rare inherited prion disease characterized by sleep, autonomic, a...
none3The book chapter describes the epidemiology, genetics, clinical features, neuropathology, molec...
Fatal Familial Insomnia is a hereditary prion disease characterized by a mutation at codon 178 of th...
In 1986, we reported two anatomoclinical observations of a familial condition that we called "fatal ...
Fatal familial insomnia (FFI) is an extremely rare autosomal dominant prion disease. The chief clini...
Fatal familial insomnia (FFI) is an inherited prion disease linked to a mutation at codon 178 of the...
The authors report a new kindred with fatal familial insomnia (FFI)--an inherited prion disease. The...
Our aim was to develop a detailed clinical description of fatal familial insomnia in a large patient...
This review study was carried out to educate people about a rare genetic disorder that is fatal fami...
A previously well 54-?year-old woman presented with a short history of diplopia, cognitive decline, ...
Univ Fed Sao Paulo, Div Gen Neurol, Sao Paulo, BrazilUniv Fed Sao Paulo, Ataxia Unit, Sao Paulo, Bra...
Introduction. Fatal familial insomnia (FFI) is one of the transmissible spongiform encephathalopathi...
In 1986, Lugaresi et al. described several patients with an autosomal-dominant neurodegenerative dis...
BACKGROUND: In absence of a positive family history, the diagnosis of fatal familial insomnia (FFI) ...
Abstract Background Fatal familial insomnia (FFI) is a rare autosomal dominant disease caused by the...
Fatal familial insomnia (FFI) is a rare inherited prion disease characterized by sleep, autonomic, a...
none3The book chapter describes the epidemiology, genetics, clinical features, neuropathology, molec...
Fatal Familial Insomnia is a hereditary prion disease characterized by a mutation at codon 178 of th...
In 1986, we reported two anatomoclinical observations of a familial condition that we called "fatal ...
Fatal familial insomnia (FFI) is an extremely rare autosomal dominant prion disease. The chief clini...
Fatal familial insomnia (FFI) is an inherited prion disease linked to a mutation at codon 178 of the...
The authors report a new kindred with fatal familial insomnia (FFI)--an inherited prion disease. The...
Our aim was to develop a detailed clinical description of fatal familial insomnia in a large patient...
This review study was carried out to educate people about a rare genetic disorder that is fatal fami...
A previously well 54-?year-old woman presented with a short history of diplopia, cognitive decline, ...
Univ Fed Sao Paulo, Div Gen Neurol, Sao Paulo, BrazilUniv Fed Sao Paulo, Ataxia Unit, Sao Paulo, Bra...
Introduction. Fatal familial insomnia (FFI) is one of the transmissible spongiform encephathalopathi...
In 1986, Lugaresi et al. described several patients with an autosomal-dominant neurodegenerative dis...
BACKGROUND: In absence of a positive family history, the diagnosis of fatal familial insomnia (FFI) ...
Abstract Background Fatal familial insomnia (FFI) is a rare autosomal dominant disease caused by the...
Fatal familial insomnia (FFI) is a rare inherited prion disease characterized by sleep, autonomic, a...
none3The book chapter describes the epidemiology, genetics, clinical features, neuropathology, molec...